Litcius/Paper detail

Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Bright Thilagar, Aditya Ghosh, Jerome Nguyen, Regan N. Theiler, Myra Wick, Ryan T. Hurt, Raymund R. Razonable, Ravindra Ganesh

2022Obstetrics and Gynecology30 citationsDOIOpen Access PDF

Abstract

In Brief Anti-spike monoclonal antibody therapy may be effective for pregnant women with coronavirus disease 2019 (COVID-19).

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Monoclonal antibodyCoronavirusMedicineVirologySpike (software development)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseAntibodyMonoclonalImmunologyInternal medicineInfectious disease (medical specialty)OutbreakManagementEconomicsCOVID-19 Impact on ReproductionPregnancy and Medication ImpactEctopic Pregnancy Diagnosis and Management
Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) | Litcius